Guardant Health director Ian T. Clark disposes of common shares worth $2.25 million
GH•Director reports option exercises and share sales
Guardant Health director Ian T. Clark reported option exercises on Aug. 4, 2026, acquiring 9,088 common shares at USD 50.57 to USD 91.11.
The shares were held indirectly via the Thornton-Clark Family Trust, with holdings rising to 17,155 shares before sales.
Clark also reported sales of 14,180 shares on Aug. 4 at weighted average prices of USD 158.8 to USD 158.98.
Indirect holdings ended the day at 2,975 shares.
